Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Riccardo Scotto, Antonio Riccardo Buonomo, Stefania De Pascalis, Mariagiovanna Nerilli, Biagio Pinchera, Laura Staiano, Simona Mercinelli, Letizia Cattaneo, Maria Stanzione, Gianfranca Stornaiuolo, Salvatore Martini, Vincenzo Messina, Carmine Coppola, Nicola Coppola & Ivan Gentile. (2021) Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life ‘LIver Network Activity’ (LINA) cohort update results. Expert Review of Gastroenterology & Hepatology 15:9, pages 1057-1063.
Read now
Read now
Emanuela Zappulo, Riccardo Scotto, Antonio Riccardo Buonomo, Alberto Enrico Maraolo, Biagio Pinchera & Ivan Gentile. (2020) Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C. Expert Opinion on Pharmacotherapy 21:3, pages 261-273.
Read now
Read now
Guglielmo Borgia, Riccardo Scotto & Antonio Riccardo Buonomo. (2019) An update on recent developments in the search for hepatitis C virus therapies with pan-genotypic efficacy. Expert Opinion on Investigational Drugs 28:5, pages 395-397.
Read now
Read now
Yosuke Takahashi, Yuki Araie, Daiki Nomura, Yuki Takahashi, Kohei Sano, Hideo Saji, Yoshinobu Takakura & Makiya Nishikawa. (2018) Construction of nanostructured DNA harbouring phosphorodiamidate morpholino oligonucleotide for controlled tissue distribution in mice. Journal of Drug Targeting 26:4, pages 373-381.
Read now
Read now
Guglielmo Borgia, Alberto Enrico Maraolo, Salvatore Nappa, Ivan Gentile & Antonio Riccardo Buonomo. (2018) NS5B polymerase inhibitors in phase II clinical trials for HCV infection. Expert Opinion on Investigational Drugs 27:3, pages 243-250.
Read now
Read now
Yanyan Yang, Tao Yu, Shaoyan Jiang, Yinfeng Zhang, Mengpeng Li, Ningning Tang, Murugavel Ponnusamy, Jian-Xun Wang & Pei-Feng Li. (2017) miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204. Expert Opinion on Therapeutic Patents 27:9, pages 1021-1029.
Read now
Read now
Articles from other publishers (7)
Krittika Chatterjee, Sagheerah Lakdawala, Sheikh Shahnawaz Quadir, Dinesh Puri, Dinesh Kumar Mishra, Garima Joshi, Sanjay Sharma & Deepak Choudhary. (2023) siRNA-Based Novel Therapeutic Strategies to Improve Effectiveness of Antivirals: An Insight. AAPS PharmSciTech 24:6.
Crossref
Crossref
Lívia Victor, Renata Perez, Flávia Fernandes, Juliana Piedade, Cristiane A. Villela-Nogueira & Gustavo Pereira. (2022) Results of interferon-free treatment for HCV-infected patients with decompensated cirrhosis from a Brazilian real-life cohort. Medicine 101:35, pages e30097.
Crossref
Crossref
Antonio Riccardo Buonomo, Riccardo Scotto, Carmine Coppola, Biagio Pinchera, Giulio Viceconte, Costanza Maria Rapillo, Laura Staiano, Mariarosaria Saturnino, Ferdinando Scarano, Federica Portunato, Mariantonietta Pisaturo, Stefania De Pascalis, Salvatore Martini, Grazia Tosone, Salvatore Nappa, Nicola Coppola & Ivan Gentile. (2020) Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence. Medicine 99:6, pages e18948.
Crossref
Crossref
Riccardo Scotto, Antonio Riccardo Buonomo, Nicola Schiano Moriello, Alberto Enrico Maraolo, Emanuela Zappulo, Biagio Pinchera, Ivan Gentile & Guglielmo Borgia. (2019) Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus Infection. Reviews on Recent Clinical Trials 14:3, pages 173-182.
Crossref
Crossref
Ivan Gentile, Riccardo Scotto, Carmine Coppola, Laura Staiano, Daniela Caterina Amoruso, Teresa De Simone, Federica Portunato, Stefania De Pascalis, Salvatore Martini, Margherita Macera, Giulio Viceconte, Grazia Tosone, Antonio Riccardo Buonomo, Guglielmo Borgia & Nicola Coppola. (2018) Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort). Hepatology International 13:1, pages 66-74.
Crossref
Crossref
Sara Moses, Ulf Andersson & Martin Billger. 2018. Early Drug Development. Early Drug Development
499
526
.
A. Robert MacLeod & Stanley T. Crooke. (2017) RNA Therapeutics in Oncology: Advances, Challenges, and Future Directions. The Journal of Clinical Pharmacology 57, pages S43-S59.
Crossref
Crossref